Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 81,257 $ 205,728
Derivative instruments   49,019
Other current assets 2,797 3,672
Total current assets 84,054 258,419
Investment in Charter, accounted for using the equity method 11,835,613 9,315,253
Other tangible and intangible assets, net 12,073 15,803
Other assets 49 1,485
Total assets 11,931,789 9,590,960
Current liabilities:    
Accounts payable and accrued liabilities 5,381 7,931
Current portion of debt   400,000
Deferred revenue and other current liabilities 5,168 4,185
Total current liabilities 10,549 412,116
Debt 497,370 198,512
Deferred income tax liabilities 932,593 504,644
Other liabilities 4,376 2,596
Total liabilities 1,444,888 1,117,868
Equity    
Preferred stock
Additional paid-in capital 7,907,900 7,945,883
Accumulated other comprehensive earnings, net of taxes 8,424 7,656
Retained earnings 2,568,764 517,736
Total equity 10,486,901 8,473,092
Commitments and contingencies
Total liabilities and equity 11,931,789 9,590,960
Series A common stock    
Equity    
Common stock 262 262
Total equity 262 262
Series B common stock    
Equity    
Common stock 25 25
Total equity 25 25
Series C common stock    
Equity    
Common stock 1,526 1,530
Total equity $ 1,526 $ 1,530